XENETIC BIOSCIENCES, INC. Proceeds from Issuance of Debt
XENETIC BIOSCIENCES, INC. (XBIO) reported Proceeds from Issuance of Debt of $100.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2022-03-22
- XENETIC BIOSCIENCES, INC. proceeds from issuance of debt for the quarter ending 2017-12-31 was $0.00.
- XENETIC BIOSCIENCES, INC. proceeds from issuance of debt for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- XENETIC BIOSCIENCES, INC. proceeds from issuance of debt for the quarter ending 2017-06-30 was $0.00.
- XENETIC BIOSCIENCES, INC. proceeds from issuance of debt for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- XENETIC BIOSCIENCES, INC. proceeds from issuance of debt for fiscal 2021 was $100.00K.
- XENETIC BIOSCIENCES, INC. proceeds from issuance of debt for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- XENETIC BIOSCIENCES, INC. proceeds from issuance of debt for fiscal 2016 was $4.50M, a 45.16% increase from fiscal 2015.
- XENETIC BIOSCIENCES, INC. proceeds from issuance of debt for fiscal 2015 was $3.10M.
| Period end | Proceeds from Issuance of Debt 3 month | Proceeds from Issuance of Debt 6 month | Proceeds from Issuance of Debt 9 month | Proceeds from Issuance of Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $100.00K 10-K · filed 2022-03-22 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $0.00 derived: sum of 2 quarters · filed 2018-03-30 | $0.00 derived: sum of 3 quarters · filed 2018-03-30 | $0.00 10-K · filed 2018-03-30 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-11-14 | $0.00 10-Q · filed 2017-11-14 | $0.00 derived: sum of 4 quarters · filed 2018-03-30 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | $0.00 derived: sum of 3 quarters · filed 2018-03-30 | $1.00M derived: sum of 4 quarters · filed 2018-03-30 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 | $0.00 derived: sum of 2 quarters · filed 2018-03-30 | $1.00M derived: sum of 3 quarters · filed 2018-03-30 | $1.00M derived: sum of 4 quarters · filed 2018-03-30 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $1.00M derived: sum of 2 quarters · filed 2018-03-30 | $1.00M derived: sum of 3 quarters · filed 2018-03-30 | $4.50M 10-K · filed 2018-03-30 |
| 2016-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $1.00M derived: sum of 2 quarters · filed 2017-11-14 | $4.50M 10-Q · filed 2017-11-14 | $4.50M derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $3.50M 10-Q · filed 2017-08-14 | $3.50M derived: sum of 3 quarters · filed 2017-08-14 | $6.50M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $3.50M 10-Q · filed 2017-05-15 | $3.50M derived: sum of 2 quarters · filed 2017-05-15 | $6.50M derived: sum of 3 quarters · filed 2017-05-15 | $6.60M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $3.00M derived: sum of 2 quarters · filed 2017-03-31 | $3.10M derived: sum of 3 quarters · filed 2017-03-31 | $3.10M 10-K · filed 2017-03-31 |
| 2015-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $3.10M derived: sum of 2 quarters · filed 2016-11-14 | $3.10M 10-Q · filed 2016-11-14 | $3.10M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $100.00K 10-Q · filed 2016-08-15 | $100.00K derived: sum of 3 quarters · filed 2016-08-15 | |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-16 | $0.00 derived: sum of 2 quarters · filed 2016-05-16 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $0.00 10-K · filed 2016-03-30 | ||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |